Balentine LLC’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-9,896
Closed -$343K – 613
2023
Q4
$343K Buy
9,896
+3,325
+51% +$115K 0.01% 357
2023
Q3
$238K Buy
+6,571
New +$244K 0.01% 423
2023
Q2
– Sell
-19,747
Closed -$913K – 596
2023
Q1
$913K Sell
19,747
-6,287
-24% -$293K 0.03% 196
2022
Q4
$1.21M Sell
26,034
-1,872
-7% -$85.1K 0.04% 159
2022
Q3
$1.22M Buy
27,906
+5,314
+24% +$244K 0.05% 131
2022
Q2
$957K Buy
22,592
+13,336
+144% +$565K 0.04% 209
2022
Q1
$403K Buy
+9,256
New +$429K 0.01% 340
2020
Q3
– Sell
-438
Closed -$16K – 427
2020
Q2
$16K Buy
+438
New +$14.8K ﹤0.01% 440
2020
Q1
– Sell
-701
Closed -$30K – 676
2019
Q4
$30K Buy
+701
New +$28K ﹤0.01% 268

Other funds holding G

Balentine LLC's G Position: Q1 2024 in Review

Balentine LLC sold out of Genpact (G) in Q1 2024, closing a stake of 9,896 shares — an estimated $343K sold.

Balentine LLC first reported a position in G in Q4 2019 and held it in 9 quarters. The position peaked at $1.22M in Q3 2022. 364 funds tracked by Wall St. Rank hold G as of Q1 2024.

  • Balentine LLC reported no remaining Genpact position as of Q1 2024 after selling out during the quarter.
  • Balentine LLC sold 9,896 Genpact shares in Q1 2024, an estimated $343K.
  • Balentine LLC first reported a position in Genpact in Q4 2019 and held it in 9 quarters.
  • Balentine LLC's Genpact position peaked at $1.22M in Q3 2022.
  • 364 funds tracked by Wall St. Rank held Genpact as of Q1 2024.

Based on Balentine LLC's 13F filing for Q1 2024, filed 15 May 2024.